Traska, A.-K.; Nowacki, T.M.; Vollenberg, R.; Rennebaum, F.; Meier, J.A.; Schomacher, T.; Reinartz Groba, S.N.; Fischer, J.; Trebicka, J.; Tepasse, P.-R.
Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients. Cells 2024, 13, 741.
https://doi.org/10.3390/cells13090741
AMA Style
Traska A-K, Nowacki TM, Vollenberg R, Rennebaum F, Meier JA, Schomacher T, Reinartz Groba SN, Fischer J, Trebicka J, Tepasse P-R.
Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients. Cells. 2024; 13(9):741.
https://doi.org/10.3390/cells13090741
Chicago/Turabian Style
Traska, Ann-Kristin, Tobias Max Nowacki, Richard Vollenberg, Florian Rennebaum, Jörn Arne Meier, Tina Schomacher, Sara Noemi Reinartz Groba, Julia Fischer, Jonel Trebicka, and Phil-Robin Tepasse.
2024. "Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients" Cells 13, no. 9: 741.
https://doi.org/10.3390/cells13090741
APA Style
Traska, A.-K., Nowacki, T. M., Vollenberg, R., Rennebaum, F., Meier, J. A., Schomacher, T., Reinartz Groba, S. N., Fischer, J., Trebicka, J., & Tepasse, P.-R.
(2024). Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients. Cells, 13(9), 741.
https://doi.org/10.3390/cells13090741